Ainhoa Madariaga - Concepedia

Author

Ainhoa Madariaga

Also Known As

A Madariaga, A. Elorriaga Madariaga, A. Madariaga, Ainhoa Madariaga, Aurora Madariaga, Jenei, Kristina, Madariaga, Abraham

234

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Princess Margaret Cancer Centre University Health Network University of Toronto Hospital Universitario 12 De Octubre Research Institute Hospital 12 de Octubre

About

Ainhoa Madariaga is an author at Princess Margaret Cancer Centre specializing in medicine, cancer therapeutics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	72
2	Health Sciences	2	2	29
3	Emergency Medicine	1	1	32
4	Hospital Medicine	1	1	32
5	Medical Laboratory Science	1	1	32

Ainhoa Madariaga

Publications

336

Citations

H-Index

Page 1

	Year	Citations
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression Stéphanie Lheureux, Ana Oaknin, Swati Garg, Clinical Cancer Research	2020	126
A cost-analysis of suspected adverse drug reactions in a hospital emergency ward I. Ayani, C Aguirre, Garazi Gutiérrez, Pharmacoepidemiology and Drug Safety DiagnosisHospital Emergency WardEmergency CareAdverse Drug ReactionHospital Medicine	1999	32
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression Stéphanie Lheureux, Stephenie D. Prokopec, Leslie E. Oldfield, Clinical Cancer Research	2023	28
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma Ainhoa Madariaga, Swati Garg, Naïri Tchrakian, Nature Communications	2023	25
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry Jitendra PS. Sawhney, V A Kothiwale, Vikas Bisne, Indian Heart Journal	2018	21
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, Cancer Research Communications	2022	16
Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non–Small-Cell Lung Cancer Patients Laura Mezquita, Amparo Benito, Alberto Ruano‐Raviña, Clinical Lung Cancer Indoor RadonMedicinePathologyBronchial NeoplasmCancer Treatment	2019	15
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort Rodrigo Sánchez-Bayona, Alfonso López de, Yolanda Jeréz Gilarranz, Breast Cancer Research and Treatment	2024	15
Evolve: A post PARP inhibitor clinical translational phase II trial of cediranib-olaparib in ovarian cancer—A Princess Margaret Consortium – GCIG Phase II Trial. Stéphanie Lheureux, Ana Oaknin, Swati Garg, Journal of Clinical Oncology MedicineCancer ManagementMetronomic TherapyPharmacologyClinical Trials	2019	14
MASCC Multidisciplinary Evidence-Based Recommendations for the Management of Malignant Bowel Obstruction in Advanced Cancer Ainhoa Madariaga, Jenny Lau, Arunangshu Ghoshal, Research Square (Research Square)	2021	12

Page 1